Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Livschitz LeonardDirector, CHIEF EXECUTIVE OFFICER |  GDYNGRID DYNAMICS HOLDINGS, INC.Open-market sale · 10b5-1 plan | SELL | $120K 10.0K sh |
| Oct 30, 2026 traded Oct 30, 2026 |
| 14 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $315K 2,667 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Siegfried Erin FreundChief Legal Counsel /Corp Sec |  NWBINorthwest Bancshares, Inc.Tax withholding | F | $26K 1,708 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Scheiwer Mark JEVP, CFO & CAO |  SMGSCOTTS MIRACLE-GRO COGrant or award | A | — 2,163 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Hardy AndrewEVP, Chief Sales Officer |  NXPINXP Semiconductors N.V.Option exercise | M | — 1,080 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Arrigunaga Gomez del Campo JavierDirector |  SCCOSOUTHERN COPPER CORP/Grant or award | A | — 400 sh | Oct 30, 2026 traded Oct 30, 2026 |
| 13 | vant Hoff GrahamDirector |  ANNAAleAnna, Inc.Option exercise | M | — 20.2K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 13 | Valenzuela Rionda Jose PedroDirector | SCCOSOUTHERN COPPER CORP/ Grant or award | A | — 400 sh | Oct 30, 2026 traded Oct 30, 2026 |
| 13 | Juvenal Tobin WChief Commercial Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $196K 5,341 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Wunsch Scott MCEO, Logistics |  SRTAStrata Critical Medical, Inc.Grant or award | A | — 57.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Charters WilliamDirector |  RGSREGIS CORPGrant or award | A | — 2,857 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | Wunsch Scott MCEO, Logistics | SRTAStrata Critical Medical, Inc. Grant or award | A | — 57.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 13 | PAEPER HOLLY BethDirector |  LFUSLITTELFUSE INC /DEGrant or award | A | $25K 62 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 13 | Ronald Ivan EdwardChief Financial Officer | ANNAAleAnna, Inc. Option exercise | M | — 13.3K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 12 | Grimme ArneDirector |  NBISNebius Group N.V.Open-market purchase · 10b5-1 plan | BUY | $25K 148 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 12 | Hardy AndrewEVP, Chief Sales Officer | NXPINXP Semiconductors N.V. Tax withholding | F | $139K 550 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 12 | Betz WilliamEVP & CFO | NXPINXP Semiconductors N.V. Tax withholding | F | $107K 423 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 12 | Sanders DaxPresident |  KMIKINDER MORGAN, INC.Gift | G | — 1,600 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 11 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $95K 1,904 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 11 | Hancock MarkDirector, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $214K 4,280 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 10 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $241K 7,500 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 10 | Glazer David A.See Remarks | PLTRPalantir Technologies Inc. Grant or award | A | — 211.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Wunsch Scott MCEO, Logistics | SRTAStrata Critical Medical, Inc. Grant or award | A | — 1,416 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner |  ACTUACTUATE THERAPEUTICS, INC.Grant or award | A | — 682.9K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 682.9K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 48.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.5K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 133.1K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 824.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Jacobs Kevin JSee Remarks |  HLTHilton Worldwide Holdings Inc.Option exercise | M | — 12.8K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 126.2K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Markley John D. Jr.Director |  IDCCInterDigital, Inc.Grant or award | A | — 8 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Baker JeffPrincipal Accounting Officer | CRWVCoreWeave, Inc. Option exercise | M | — 12.5K sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 824.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 269.3K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Rankin Jean FDirector | IDCCInterDigital, Inc. Grant or award | A | — 2 sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 48.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 87.7K sh | Oct 30, 2026 traded Oct 28, 2026 |
| 9 | Carey Stephen P.SVP & CFO |  ANIPANI PHARMACEUTICALS INCOpen-market sale · 10b5-1 plan | SELL | $208K 2,850 sh | Oct 30, 2026 traded Oct 29, 2026 |
| 9 | BIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 195.0K sh | Oct 30, 2026 traded Oct 28, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K